ZFP36 Inhibits Gastric Cancer Progression by enhancing expression of LIPG and binding its 3'UTR of RNA

The evaluation of RNA-binding proteins (RBPs) is based on their RNA-binding capacity and the yield of protein recovered in assays. To determine the specificity of ZFP36's RNA interactions in AGS cells, we performed iRIP-seq to identify its directly bound mRNA targets.